Tasurgratinib (E-7090) succinate is a novel and potent FGFR1/2/3/4 (fibroblast growth factor receptor) inhibitor with anticancer activity. Inhibits FGFR1, -2, and -3 with IC50 of 0.71, 0.50 and 1.2 nM.

纯度：≥98%

CAS：1879965-80-6